-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, L8Xwx89/6KfZIEny1JR/0sO7zQLj6xf+1ZrzxNIuk960TkVSJrBEFsKfc3oYd2f2 Lkr7Bhe0QC0fqa8KNSK2JA== 0000885988-99-000014.txt : 19990217 0000885988-99-000014.hdr.sgml : 19990217 ACCESSION NUMBER: 0000885988-99-000014 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INTEGRAMED AMERICA INC CENTRAL INDEX KEY: 0000885988 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 061150326 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-43053 FILM NUMBER: 99543470 BUSINESS ADDRESS: STREET 1: ONE MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 BUSINESS PHONE: 9142538000 MAIL ADDRESS: STREET 1: 1 MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577-2100 FORMER COMPANY: FORMER CONFORMED NAME: IVF AMERICA INC DATE OF NAME CHANGE: 19950720 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CANET GERALDO CENTRAL INDEX KEY: 0001054855 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: ONE MANHATTANVILLE RD STREET 2: C/O INTEGRAMED AMERICA INC CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 9142538000 MAIL ADDRESS: STREET 1: ONE MANHATTANVILLE RD CITY: PURCHASE STATE: NY ZIP: 10577 SC 13G 1 SCHEDULE 13G ------------------------------ OMB APPROVAL ------------------------------ OMB Number Expires: Estimated average burden hours per response ....... 0.5 ------------------------------ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. )(1) IntegraMed America, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 45810N 30 2 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 1998 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-(c) [_] Rule 13d-1(d) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (SC13G-07/98) CUSIP No. 45810N 30 2 13G Page of Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) Gerardo Canet ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION USA ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER: 576,624 shares (see Item 4(c)(i)). SHARES _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER: 92,423 shares REPORTING _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 576,624 shares (see Item 4(a)). ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 11.39% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON*: IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 45810N 30 2 13G Page of Pages ________________________________________________________________________________ Item 1(a). Name of Issuer: IntegraMed America, Inc. ________________________________________________________________________________ Item 1(b). Address of Issuer's Principal Executive Offices: One Manhattanville Road Purchase, NY 10577 ________________________________________________________________________________ Item 2(a). Name of Person Filing: Gerardo Canet ________________________________________________________________________________ Item 2(b). Address of Principal Business Office, or if None, Residence: See Item 1(b). ________________________________________________________________________________ Item 2(c). Citizenship: USA ________________________________________________________________________________ Item 2(d). Title of Class of Securities: Common Stock ________________________________________________________________________________ Item 2(e). CUSIP Number: 45810N 30 2 ________________________________________________________________________________ Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [_] Investment company registered under Section 8 of the Investment Company Act. (e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [X] CUSIP No. 45810N 30 2 13G Page of Pages Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: Mr. Canet benefically owns 576,624 shares of the Issuer's securities, consisting of 31,250 shares of Issuer's Common Stock owned by Mr. Canet, options exercisable within 60 days to purchase 61,173 shares of Issuer's Common Stock and 484,201 shares of Issuer's Common Stock held by certain individuals with respect to which Mr. Canet holds a proxy to vote on the matters described in Item 4 (c)(i). (b) Percent of class: 11.39% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: Mr. Canet has sole power to vote or to direct the vote: 576,624 shares, consisting of 31,250 shares of Issuer's Common Stock owned by Mr. Canet, options exercisable within 60 days to purchase 61,173 shares of Issuer's Common Stock and 484,201 shares of Issuer's Common Stock held by certain individuals with respect to which Mr. Canet holds a proxy to vote for a two-year period with respect: (a) to the election of Directors or any amendment to Issuer's Certificate of Incorporation affecting Directors and (b) any change in stock options for management and Directors. (ii) Shared power to vote or to direct the vote (iii) Sole power to dispose or to direct the disposition of 92,423 shares of Common Stock, (iv) Shared power to dispose or to direct the disposition of ________________________________________________________________________________ Item 5. Ownership of Five Percent or Less of a Class. Not applicable. ________________________________________________________________________________ Item 6. Ownership of More Than Five Percent on Behalf of Another Person. 484,201 shares, or 9.6%, represent shares for which Mr. Canet holds a voting proxy on the matters described in Item 4(c)(i). ________________________________________________________________________________ Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable ________________________________________________________________________________ Item 8. Identification and Classification of Members of the Group. Not applicable. ________________________________________________________________________________ Item 9. Notice of Dissolution of Group. ________________________________________________________________________________ Item 10. Certifications. "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect." SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 16, 1999 ---------------------------------------- (Date) /s/Gerardo Canet ---------------------------------------- (Signature) President and Chief Executive Officer ---------------------------------------- (Name/Title) Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). -----END PRIVACY-ENHANCED MESSAGE-----